|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:morphine_sulfate
|
|
gptkbp:approvedBy
|
1987
|
|
gptkbp:ATCCode
|
N02AA01
|
|
gptkbp:brand
|
gptkb:morphine
|
|
gptkbp:compatibleWith
|
as-needed pain relief
|
|
gptkbp:contraindication
|
respiratory depression
acute asthma
paralytic ileus
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Schedule_II_(US)
|
|
gptkbp:duration
|
8-12 hours
|
|
gptkbp:eliminatedIn
|
renal
|
|
gptkbp:form
|
gptkb:tablet
extended-release tablet
|
|
gptkbp:genericAvailable
|
yes
|
|
gptkbp:halfLife
|
2-4 hours (morphine)
|
|
gptkbp:indication
|
chronic pain
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Purdue_Pharma
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:riskFactor
|
addiction
overdose
abuse potential
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
constipation
drowsiness
respiratory depression
|
|
gptkbp:usedFor
|
moderate to severe pain
|
|
gptkbp:bfsParent
|
gptkb:Contin
gptkb:morphine
gptkb:Morphine
gptkb:Purdue_Pharma
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MS Contin
|